Trexquant Investment’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.53M | Sell |
109,242
-3,982
| -4% | -$55.7K | 0.02% | 980 |
|
|
2025
Q1 | $1.54M | Buy |
113,224
+52,568
| +87% | +$715K | 0.02% | 951 |
|
|
2024
Q4 | $1.24M | Buy |
60,656
+36,122
| +147% | +$736K | 0.01% | 1027 |
|
|
2024
Q3 | $715K | Buy |
+24,534
| New | +$715K | 0.01% | 1158 |
|
|
2023
Q4 | – | Sell |
-42,349
| Closed | -$874K | – | 1509 |
|
|
2023
Q3 | $874K | Sell |
42,349
-24,586
| -37% | -$507K | 0.02% | 801 |
|
|
2023
Q2 | $1.98M | Sell |
66,935
-13,589
| -17% | -$401K | 0.05% | 496 |
|
|
2023
Q1 | $1.86M | Buy |
80,524
+57,669
| +252% | +$1.33M | 0.05% | 484 |
|
|
2022
Q4 | $636K | Sell |
22,855
-2,774
| -11% | -$77.1K | 0.02% | 818 |
|
|
2022
Q3 | $787K | Buy |
+25,629
| New | +$787K | 0.03% | 622 |
|
|
2021
Q2 | – | Sell |
-16,192
| Closed | -$925K | – | 1173 |
|
|
2021
Q1 | $925K | Buy |
+16,192
| New | +$925K | 0.08% | 300 |
|
|
2020
Q4 | – | Sell |
-40,025
| Closed | -$1.43M | – | 1112 |
|
|
2020
Q3 | $1.43M | Buy |
+40,025
| New | +$1.43M | 0.09% | 303 |
|
|
2018
Q3 | – | Sell |
-10,151
| Closed | -$155K | – | 994 |
|
|
2018
Q2 | $155K | Buy |
+10,151
| New | +$155K | 0.01% | 813 |
|